U.S. markets close in 4 hours 27 minutes

  • S&P 500

    4,125.28
    -37.98 (-0.91%)
     

  • Dow 30

    33,787.44
    -290.19 (-0.85%)
     

  • Nasdaq

    13,722.90
    -191.86 (-1.38%)
     

  • Russell 2000

    2,179.08
    -52.92 (-2.37%)
     

  • Crude Oil

    61.90
    -1.48 (-2.34%)
     

  • Gold

    1,774.50
    +3.90 (+0.22%)
     

  • Silver

    25.84
    +0.00 (+0.01%)
     

  • EUR/USD

    1.2039
    -0.0001 (-0.01%)
     

  • 10-Yr Bond

    1.5700
    -0.0310 (-1.94%)
     

  • GBP/USD

    1.3940
    -0.0044 (-0.31%)
     

  • USD/JPY

    108.0400
    -0.1100 (-0.10%)
     

  • BTC-USD

    55,103.48
    -884.27 (-1.58%)
     

  • CMC Crypto 200

    1,243.27
    +8.86 (+0.72%)
     

  • FTSE 100

    6,865.65
    -134.43 (-1.92%)
     

  • Nikkei 225

    29,100.38
    -584.99 (-1.97%)
     

Global In Vitro Diagnostics Market (2020 to 2025) - Featuring Abbott Diagnostics, Bio-Rad and Danaher Among Others

·7 min read

DUBLIN, April 20, 2021 /PRNewswire/ -- The "In Vitro Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo
Research and Markets Logo

The scope of this study is global. The research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines IVD market drivers, as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas:

  • Structure and current market size of the IVD market as outlined with forecasts through 2025.

  • Impact of chronic diseases, growing and aging populations.

  • Current technology and product suppliers and key innovations.

  • A look at the IVD industry and trends affecting the market.

  • Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics).

  • A global overview showing market data for North America, Europe, Asia-Pacific and Latin America, Africa and the Middle East (LAAM).

  • Emerging opportunities and potential investment opportunity areas for IVD.

  • Technology patent trends relating to IVD.

  • Profiles for more than 20 companies in the industry with significant contributions and market shares.

Report Includes:

  • 47 data tables and 21 additional tables

  • An overview of the global market for in vitro diagnostics (IVD) within the industry

  • Analyses of global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025

  • Assessment of market dynamics such as drivers, restraints, opportunities, and identification of growth-inhibiting areas that affect the global market

  • Evaluation of market size and forecast, and technological advancements within the industry; and market share analysis of the global IVD market by application, segment and region

  • A look at how the rise in the number of diseases like respiratory infections, hospital-acquired infections (HAI), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories

  • Coverage of technologies such as IVD for neglected infectious diseases, chemistry-based portable analysis and discussion on advantages of microfluidic platform based POC tests

  • Detailed description on COVID-9 pandemic, including symptoms, and progression; information on coronavirus disease 2019 testing basics and impact analysis of COVID-19 on the IVD market

  • Comprehensive company profiles of major market players, including Abbott Diagnostics Inc., Beckman Coulter, Becton, Dickinson and Co., Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthcare and Thermo Fisher Scientific Inc.

IVDs are of significant value to the general public, as they are deemed not only as indispensable tools of medical diagnoses but also as decision-making aids for disease prevention and timely treatment to enhance well-being and keep healthcare costs under check. In addition, IVDs are also one of the vital aids that address the needs of governments, payers and patients by delivering optimal, individualized and affordable treatments.

These factors and rapid technological developments should drive the growth of the IVD market in the next five years. The market is also expected to be driven by the aging demographics of the developed world, the rising demand and improving healthcare infrastructure in the developing world and, most importantly, the shift from curative to preventive healthcare for both infectious and chronic diseases such as diabetes. Further, two emerging segments of IVDs companion diagnostics and next-generation sequencing techniques - are expected to contribute to the market growth of IVDs through the decade.

Global Market Trends

The most significant market trend during 2020 was the origin and global spread of COVID-19, the disease caused by the novel coronavirus. Originating in late 2019 in China, the virus quickly became a global pandemic. Global health organizations and diagnostic manufacturers quickly developed and approved tests for the virus. This effort overwhelmed all other trends in 2020. One effect of this activity was a complete halt of merger and acquisition activity among major diagnostic manufacturers in 2020.

Because of its large population and its position as a medical technology innovation hub, North America is the global leader in terms of IVD utilization. It remains the largest market. The emerging markets of India, China, Russia and Brazil are poised to grow at double-digit growth rates due to rising incomes, growing healthcare budgets and heightened health awareness among the population.

Key Topics Covered:

Chapter 1 Introduction

  • Study Goals and Objectives

  • Reasons for Doing This Study

  • Intended Readership

  • Scope of Report

  • Methodology

  • Geographic Breakdown

  • Analyst's Credentials

  • Custom Research

  • Related Reports

Chapter 2 Summary and Highlights

  • Global Market Trends

Chapter 3 Market Landscape

  • COVID-19 Global Pandemic

  • Coronavirus Disease 2019 Testing Basics

  • Diagnostic Tests with Alternative Options

  • Molecular Diagnostic Tests

  • Increasing Access to Testing

  • Antigen Tests

  • Antibody (Serology) Tests

  • In Vitro Diagnostic Testing EUAs

  • Diagnostic Tests

  • Serology/Antibody Tests

  • Tests for the Management of COVID-19 Patients

  • Market Overview and Segmentation

  • Key Findings

  • Factors Influencing the Global IVD Market

  • Drivers

  • Challenges

  • Regulatory Landscape

  • IVD Regulations in North America

  • IVD Regulations in Europe

  • IVD Regulations in Asia-Pacific

  • IVD Regulations in LAAM (Latin America, Africa and Middle East)

Chapter 4 Global Market for IVD by Product Segment

  • Immunochemistry

  • POC IVD

  • Molecular Diagnostic Testing

  • Hematology

  • Clinical Microbiology

  • Tissue Diagnostic Testing

  • Trends in IVD Segments

  • Competitive Structure

  • Market Share Analysis

Chapter 5 Global Market for Immunochemistry Testing

  • Blood Gas, Electrolytes and Metabolites (BGEM)

  • Endocrine

  • Infectious Diseases

  • Cancer

  • Urinalysis

  • Diabetes

  • Cardiology

  • Blood Screening

  • Others

  • FDA Product Approvals in 2020

Chapter 6 Global Market for POC Testing

  • Glucose Testing

  • BGEM

  • Cardiac Marker Testing

  • Infectious Disease Testing

  • Pregnancy and Fertility Testing

  • Drug and Alcohol Abuse Testing

  • Hematology and Hemostasis Testing

  • Cholesterol Testing

  • Urine Chemistry Testing

  • Tumor Marker Testing

  • Other Types of POC Testing

  • FDA Product Approvals in 2020

Chapter 7 Global Market for Hematology Testing

  • Routine Hematology Tests

  • Hemostasis

  • FDA Product Approvals in 2020

Chapter 8 Global Market for Molecular Diagnostic Testing

  • Infectious Diseases

  • Blood Screening

  • Oncology

  • Genetic Testing

  • Others (Companion Diagnostics, Prenatal Genetic Tests and Rare Diseases)

  • FDA Product Approvals in 2020

Chapter 9 Global Market for Clinical Microbiology Testing

  • Blood Culture

  • General Culture (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids)

  • Identification and Antibiotic Susceptibility Testing

  • FDA Product Approvals in 2020

Chapter 10 Global Market for Tissue Diagnostic Testing

  • Cancer Diagnosis

  • Tissue Typing

  • Pathogen Detection

Chapter 11 Regional Analysis

  • Introduction

  • North America

  • Europe

  • Asia-Pacific

  • LAAM

  • International Health Expenditure and Trends

  • North America

  • Europe

  • Western Europe

  • Central and Eastern Europe

  • Asia-Pacific

  • Latin America, Africa and Middle East (LAAM)

Chapter 12 Market Trends

  • End Users

  • Trends

  • Product Categories

  • Trends

  • Technology Trends

  • Industry Developments

  • Opportunities

  • IVD for Neglected Infectious Diseases

  • Portable Devices Compatible with Simple Detection Platforms

  • Chemistry-Based Portable Analyzers

  • Improved Sample Preservation Technologies

  • New Detection Technologies

  • Alternative Technologies to PCR

  • Key Biomarkers for Diseases of the Developing World

  • Microfluidic Platform-based POC Tests for Remote Settings

  • Combining Multiple Detection Technologies into a Single Instrument

Chapter 13 Mergers and Acquisitions

Chapter 14 Patent Review

  • Coronavirus COVID-19 Diagnostics

Chapter 15 Company Profiles

  • Abbott Diagnostics Inc.

  • Alere San Diego Inc.

  • Ascensia Diabetes Care

  • Beckman Coulter (Part Of Danaher)

  • Becton Dickinson And Co.

  • Biomerieux

  • Bio-Rad

  • Danaher Corp.

  • Elitech Group

  • Hologic Inc.

  • Instrumentation Laboratory

  • Kementec A/S

  • Ortho Clinical Diagnostics

  • Roche Diagnostics Corp.

  • Quidel Corp.

  • Siemens Healthcare Diagnostics Inc.

  • Sysmex

  • Thermo Fisher Scientific Inc.

  • Transasia Bio-Medicals

  • Werfen Group

Chapter 16 Appendix

Companies Mentioned

  • Abbott Diagnostics Inc.

  • Alere San Diego Inc.

  • Ascensia Diabetes Care

  • Beckman Coulter (Part Of Danaher)

  • Becton Dickinson And Co.

  • Bio-Rad

  • Biomerieux

  • Danaher Corp.

  • Elitech Group

  • Hologic Inc.

  • Instrumentation Laboratory

  • Kementec A/S

  • Ortho Clinical Diagnostics

  • Quidel Corp.

  • Roche Diagnostics Corp.

  • Siemens Healthcare Diagnostics Inc.

  • Sysmex

  • Thermo Fisher Scientific Inc.

  • Transasia Bio-Medicals

  • Werfen Group

For more information about this report visit https://www.researchandmarkets.com/r/vps1gp


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/global-in-vitro-diagnostics-market-2020-to-2025---featuring-abbott-diagnostics-bio-rad-and-danaher-among-others-301272632.html

SOURCE Research and Markets

Recommended Stories

  • DBS to buy 13% stake in privately-held Chinese lender for $814 million

    The company said financial authorities in Singapore and China had approved the deal and was in line with its aim to expand in the rapidly growing Greater Bay Area in China. In September, DBS received approval from China's securities regulator to form a joint venture securities company in which it would have a controlling stake, allowing DBS to engage in brokering, investment consulting, securities underwriting and sponsorship in the country. Earlier on Tuesday, Reuters exclusively reported DBS was among a clutch of banks looking to bid for parts of Citigroup's consumer business in Asia.

  • IBM quarterly sales growth highest in over two years on cloud strength

    International Business Machines Corp recorded highest quarterly sales growth in more two years and beat Wall Street targets on Monday, boosted by its bets in the high-margin cloud computing business. Finance chief James Kavanaugh said cloud spending by clients in retail, manufacturing and travel industries in the United States was picking up after the initial pandemic-driven slump. Sales from its cloud computing services jumped 21% to $6.5 billion in the quarter.

  • Nikola’s Stock Selloff Accelerates as Shares Fall Below $10

    (Bloomberg) -- Nikola Corp. shares fell Tuesday to the lowest since January 2019, accelerating a selloff that has now erased all their gains since the electric-vehicle startup went public last year.The electric-truck maker -- once briefly more valuable than Ford Motor Co. -- dropped as much as 5.2% to $9.76 in New York, bringing it below the $10 level at which VectoIQ Acquisition Corp., the special-purpose acquisition company that acquired Nikola, debuted in June 2018.Nikola’s shares have lost their luster after much fanfare since it closed its reverse merger with VectoIQ in June 2020. That month, it rallied to an intraday high of $93.99, catapulting Nikola’s market capitalization above $28 billion. The company’s valuation has since slumped to $3.9 billion.Since then, it has been mired in bad news: a collapsed deal to build trucks with General Motors Co., an internal probe that found it made several inaccurate statements, and an inability to meet initial production guidance for its first commercial zero-emission vehicles.Read more: Nikola Faces Daunting Future With Far Fewer Friends Than BeforeNikola’s slump is also part of broader weakness for electric-vehicle stocks this year as the threat of competition from incumbent players increased and rapid economic growth fueled a rotation into value stocks. Now traditional automakers are making a comeback as they vow to rapidly expand their presence in the EV market, shrinking the potential market share of startups like Nikola.Last week, shares of another electric truck startup, Lordstown Motors Corp., also fell below the $10 level, the price at which the blank-check company it merged with debuted in April 2019.Shares of the big three Detroit automakers have rallied this year on aggressive plans to compete in the EV market. General Motors, Ford, and Stellantis NV -- the owner of Chrysler -- all announced plans to shift into EV technology during the March quarter, joining a growing list of peers including Volkswagen AG and BMW AG in trying to convince investors they too offer exposure to the industry.For many of Nikola’s private early investors -- including Fidelity, P. Schoenfeld Asset Management LP and ValueAct -- the slump could mean they’ve suffered losses if they’ve held onto shares.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • European Equities: Another Quiet Economic Calendar Leaves Earnings in Focus

    It’s another quiet day ahead on the economic calendar. Geopolitics, COVID-19 news, and corporate earnings will be in focus.

  • Singapore prosecution files more charges over nickel trading scandal

    Singapore prosecutors on Tuesday filed five additional charges against businessman Ng Yu Zhi in relation to a scheme that allegedly raised at least S$1 billion ($746 million) from investors to fund bogus nickel trades. The alleged fraud, which would be one of the city-state's biggest, follows a string of scandals involving Singapore trading firms that have shaken investor and banker confidence in the sector over the last year when some commodities, including nickel, have rallied strongly. The new charges of cheating against Ng were read out in Singapore's State Court.

  • Harley-Davidson hits recovery road amid focus on touring bikes

    (Reuters) -Harley-Davidson Inc on Monday raised its full-year earnings forecast after smashing analysts' quarterly profit estimates, vindicating Chief Executive Jochen Zeitz's decision to focus on more-profitable touring bikes at the expense of cheaper entry-level models. The company, however, also received a setback in the European Union - its second-biggest market - where all of its products, regardless of origin, will be subjected to a 56% import tariff from June following a new EU ruling. The ruling revokes the credentials that currently allow Harley to ship certain motorcycles to the EU from its international manufacturing facilities at a 6% tariff.

  • Bitcoin ETF From 3iQ and CoinShares, Canada’s 4th, Begins Trading on TSX

    A trio of ether ETFs were approved by Canadian regulators last week.

  • Market Wrap: Bitcoin Recovers From Sunday Slump to $56K as Doge Jumps 19%

    Volumes on the CoinDesk 20 eight spot BTC venues was over $8 billion for the first time since Feb. 23.

  • It’s time to revisit the job descriptions of managers

    New research ties the mental health of managers to the number of "illegitimate tasks" they feel they have to do as part of their job.

  • USD/JPY Forex Technical Analysis – Trade Through 108.407 Changes Main Trend to Down with 108.230 Next Target

    The direction of the USD/JPY on Monday is likely to be determined by trader reaction to 108.966.

  • IBM Shares Jump on Biggest Revenue Growth Since 2018

    (Bloomberg) -- International Business Machines Corp. shares jumped in extended trading after the company reported its biggest revenue gain in eleven quarters, driven by demand for cloud services and suggesting Chief Executive Officer Arvind Krishna’s turnaround plan is starting to bear fruit.Sales increased 1% to $17.7 billion in the three months ended Mar. 31, the Armonk, New York-based company said Monday in a statement. That beat the $17.3 billion analysts had forecast, on average, according to data compiled by Bloomberg.IBM reported first-quarter revenue growth in three of its five business segments, including Cloud and Cognitive Software, which saw a sales increase of 3.8% from a year earlier to $5.4 billion. The Global Business Services unit, which includes consulting, and the Systems unit, which includes hardware and operating systems software, also posted year-over-year sales increases.April marks a full year at the helm for Krishna, who took over as CEO from Ginni Rometty with plans to focus on artificial intelligence and the cloud to revive growth after years of stagnation. Krishna has reorganized the 109-year-old tech giant around a hybrid-cloud strategy, which allows customers to store data in private servers and on multiple public clouds, including those of rivals Amazon.com Inc. and Microsoft Corp. Total cloud revenue increased 21% to $6.5 billion in the first quarter.Krishna said he is “confident” IBM will deliver revenue growth in the second quarter and the rest of the year. “We will exit 2021 in a stronger position than we started,” he said on a conference call after the results were released.The shares increased as much as 4.9% in late trading, after closing at $133.12 in New York. The company has gained 5.8% so far this year compared with an increase of 11% for the S&P 500.Krishna attributed “increasing client adoption of our hybrid-cloud platform,” as well as growth in software and consulting, to helping the company “get off to a solid start for the year.”Last October, Krishna spun off IBM’s managed infrastructure services unit into a separate publicly traded company, which will be called Kyndryl and be based in New York. The division, currently part of IBM’s Global Technology Services division, handles day-to-day infrastructure service operations like managing client data centers and traditional information-technology support for installing, repairing and operating equipment. The unit, IBM’s biggest, has seen business shrink as customers embraced the shift to the cloud, and many clients delayed infrastructure upgrades during the pandemic. It was one of only two of IBM’s units to see revenue decline in the first quarter, with sales down 1.5%, to $6.37 billion. The spinoff is scheduled to be completed by the end of this year.IBM also said revenue from Red Hat, which it bought in 2019 for $34 billion, gained 17% in the first quarter.Earnings excluding some costs were $1.77 a share, beating the average analyst estimate of $1.65. Gross margin was 47.3%, compared with the 47.2% analysts expected.(Updates with CEO comments in the fifth paragraph. An earlier version of this story was corrected to remove reference to Cloud and Cognitive Software being the biggest unit.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Putin’s Answer to U.S. Sanctions Is More Economic Isolation

    (Bloomberg) -- Russian President Vladimir Putin is likely to respond to the latest round of U.S. sanctions threats as he has to past ones: by speeding his drive to make Russia’s economy more self-sufficient.In the seven years since Russia’s annexation of Crimea, Putin’s government and central bank have stripped back the country’s exposure to dollars, shifted assets out of the U.S. and sold a smaller share of its debt to foreigners.“The Americans are saying: be careful or we could do more, but Russia is just going to continue down the path toward economic autarky,” said Elina Ribakova, deputy chief economist at the Institute of International Finance in Washington.The administration of U.S. President Joe Biden is keeping the threat of sanctions hanging over Russia even after a sweeping round of penalties imposed last week. On Sunday, the U.S. warned of “consequences” if jailed opposition activist Alexey Navalny dies in prison.These four charts show how Putin has responded to past rounds of sanctions by increasing Russia’s economic isolation.The share of gold in Russia’s $581 billion international reserves jumped above dollars for the first time on record last year following a multi-year drive to reduce exposure to U.S. assets. The precious metal made up 24% of the central bank’s stockpile as of the end of September 2020, the latest date for which the breakdown is available. The share of dollar assets was 22%, down from more than 40% in 2018.That trend also shows up in the share of Russia’s international reserves held in the U.S., which plummeted to just under 7% by the end of September, down from about 30% before the Crimea annexation. Most of the shift happened in the second quarter of 2018 just after sanctions on aluminum giant United Co. Rusal revealed how vulnerable Russia was to sanctions.What Our Economists Say...Russia’s resilience to successive waves of sanctions provides a false sense of security. With the U.S. running out of options, the next round could be more disruptive, and the measures already in place are holding back trade and investment.-- Scott Johnson, Bloomberg EconomicsOf course, there’s only so much that Russia can do without cutting itself off entirely from the global economy. But officials in Washington are also restrained by the fact that if they go too far (as they did with the Rusal sanctions that were later revoked), they risk sending tremors through global markets.Acting on a pledge by Putin to “de-dollarize” trade, Russia has been slowly cutting back on use of the greenback in its exports with the European Union, China and India. The euro has almost overtaken the dollar in Russia’s trade with the EU and has already surpassed it in exports to China. About two-thirds of Russia’s exports to India, meanwhile, are paid for in rubles.How Virus-Panicked Markets Showed Dollar’s Still King: QuickTakeLast week’s penalties included a ban on purchases of bonds on the primary market, so the next big targets could be secondary-market debt and Russian banks’ access to the financial messaging system used for most international money transfers. Russia is already looking for alternatives to the system, known as SWIFT, to make itself less vulnerable, though attempts so far haven’t led to much.One reason the Finance Ministry wasn’t too concerned about the latest sanctions measure on government debt is that Russia has mostly been selling to local banks at its weekly auctions anyway. Borrowing was ramped up during the pandemic even though foreign demand was weak, which increased the overall size of the market and pushed down the share of foreigners.U.S. banks can still buy new debt on the secondary market after the penalties come into force in mid-June. Russia is “well positioned” for a near term market disruption because it has a high cash buffer and demand from local banks is “robust,” Fitch Ratings said in a research note published late on Friday.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • India does not see logic in U.S. putting it on currency watchlist

    India does not see any logic in the United States putting it on a monitoring list of currency manipulators, a trade ministry official said on Tuesday. "I don't understand any economic logic," Anup Wadhawan, India's commerce secretary told reporters. The Reserve Bank of India is following a policy that allows currency movements based on market forces, he said.

  • PBoC Softens Tone Toward Bitcoin, Stablecoins, Calling Them ‘Alternative Investment’

    The deputy governor said bitcoin and stablecoins were investment options and not currency during the Boao Forum on Sunday.

  • Australia's Orocobre buying Galaxy for $1.4 billion to create world No.5 lithium miner

    MELBOURNE (Reuters) -Australian lithium miner Orocobre Ltd is buying smaller domestic peer Galaxy Resources for $1.4 billion to create the world's fifth most valuable producer of the key raw material for electric vehicle batteries. The all-stock deal for A$1.78 billion ($1.38 billion)announced on Monday, which will also establish Australia's most valuable lithium miner with a A$4 billion market capitalisation, comes as demand for the material is booming amid a jump in global sales of electric vehicles. The new entity will have hard rock, brine, and chemicals assets across Australia, Argentina, Canada and Japan, and will be able to accelerate development and sell into global markets.

  • Dogecoin Eclipses XRP as 4th Largest Cryptocurrency Ahead of ‘Dogeday’

    Dogecoin briefly replaced XRP as the fourth-largest coin early Monday.

  • India is already a major IT supplier for the US—can it be more?

    "Only five US industry sectors—all manufacturing-based—have become dependent on China, whereas just about every industry now relies on India for IT."

  • Australia's Afterpay considers U.S. listing as 'buy now, pay later' takes off

    (Reuters) -Australian buy-now-pay-later company Afterpay said on Tuesday it is exploring a U.S. listing after North America became its biggest market, offering global investors an easier path to owning a stock that has boomed through the pandemic. Afterpay has tapped Goldman Sachs to advise on the listing, two sources with direct knowledge of the matter told Reuters. Goldman declined to comment.

  • Toshiba Says Potential Buyout Offer From CVC Has Stalled

    (Bloomberg) -- Toshiba Corp. said a potential acquisition offer from CVC Capital Partners has stalled after the firm submitted a new proposal that lacks sufficient information for evaluation.Toshiba revealed a preliminary approach from CVC in early April, which sent its shares soaring. Just days later, the company’s board urged caution over the discussions, warning the proposal may not lead to a transaction.In the latest chapter of the convoluted drama, Toshiba revealed it had received a letter from CVC on Monday, but it included “no specific and detailed information capable of detailed evaluation.”“It merely stated that CVC would step aside to await our guidance as to whether a privatization of Toshiba would suit management’s and the Board of Directors’ strategic objectives,” the statement said.“As this preliminary proposal lacks the required information the Board has concluded it is not possible to evaluate it,” it said.The disclosure is yet another setback for any potential buyout of the Japanese company, which also saw the resignation of its chief executive officer earlier this month. Nobuaki Kurumatani, who had previously worked at CVC, stepped down after he suffered a sharp drop in support from Toshiba employees and executives.It’s not clear whether other reported bidders will proceed after CVC. After the firm’s initial approach, private equity firm KKR & Co. and Canadian investment giant Brookfield Asset Management Inc. began exploring potential offers, Bloomberg News reported.Satoshi Tsunakawa, who took over as CEO this month, offered reassurances that Toshiba would remain a strong Japanese company and invest in research and development. His comments appeared aimed at reassuring employees and business partners in the wake of the CVC offer.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Plumber Buying Doge Shows Retail Investors’ Power in Crypto

    (Bloomberg) -- A rocky weekend for the legions that poured into all things crypto after Coinbase Global Inc.’s direct listing did little to undermine its grip on retail traders.Dogecoin rallied another 20% or so Monday, even after most of the biggest tokens, including Bitcoin slumped further. To Mike McGlone, a Bloomberg Intelligence commodity strategist, the recent run-up in the joke token is exemplary of retail’s involvement in crypto markets. His plumber told him recently that he’d bought in.To McGlone, it’s a result of the “perfect storm” of pandemic lock-ups, lots of cash in the system, and investors’ ability to speculate around the clock. “Markets will never change -- this one is just 24/7 and the easiest to access in history,” he said. It’s “a prime example of just plain gambling for fun -- unless participants lose too much money, notably because they took too much risk at the casino.”While Coinbase’s market debut was undeniably a watershed moment for crypto’s move into the mainstream, the weekend rout delivered a harsh refresher on one of the market’s basic tenets: violent price swings are common.A false report from an anonymous Twitter account that the U.S. Treasury was cracking down on crypto money laundering was enough to help send Bitcoin plunging by as much as 15% on Sunday, days after clocking in at a record of $64,870. While low weekend liquidity likely exacerbated the nose dive, the world’s largest cryptocurrency dropped another 3.5% on Monday.That an erroneous tweet can torpedo prices is a reminder that even for all the talk of Wall Street’s growing embrace of crypto, individual investors have a lot of heft to throw around. That dynamic is especially prevalent on weekends, when traditional trading desks go dark while Bitcoin and other cryptocurrencies continue to change hands. Even as Coinbase’s direct listing marks an important milestone for crypto, for institutions and traders venturing into crypto, learning to live with that volatility is a key first step.“It’s more an introduction to all the people who had gotten into Bitcoin or crypto over the last week because of Coinbase that crypto markets can be very volatile,” Philip Gradwell, chief economist at crypto data tracker Chainalysis, said by phone. “This is in some sense, nothing new if you’ve been in the industry for a few years.”Even by crypto standards, sentiment was looking stretched at the end of last week. Bitcoin soared in the lead up to Coinbase’s much-anticipated listing, bringing year-to-date gains to over 118% at one point. That enthusiasm spilled into so-called altcoins such as Dogecoin, which has soared more than 13,000% over the past year.The moves can be jarring. Roughly $9.3 billion in so-called long Bitcoin future positions were liquidated on Saturday, followed by another $700 million on Sunday, according to data from Bybt.com.Such a pullback in Bitcoin was “inevitable” given the degree of froth, Galaxy Digital founder Michael Novogratz tweeted over the weekend, adding that “we will be fine in the medium term” as institutions enter the space.Shifting the power dynamic in favor of the institutions will be the “Holy Grail” for Coinbase, BI analyst Julie Chariell said last week, given that corporations are less likely to dump their holdings as quickly as retail traders. Though individual investors made up just 36% of the exchange’s volume during the quarter ending Dec. 31, more than 90% of Coinbase’s revenue came from retail trades.Whether the cryptocurrency exchange is successful remains to be seen. But even should Bitcoin carve out a place in portfolios and on corporate balance sheets beyond the likes of MicroStrategy Inc. and Tesla Inc., the weekend will likely still belong to the individual investor.“The retail investor still dominates the crypto market,” Steven McClurg, CIO at Valkyrie Investments, said in a phone interview. “When you see action like that over the weekend, that’s just when all the institutional traders are asleep or not working.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.